引用次数
引用: 53,509
H-指数: 108
I10-指数 : 387
出版物: 759
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer
Kara N. Maxwell , Steven N. Hart , Joseph Vijai , Kasmintan A. Schrader
American Journal of Human Genetics 98 ( 5) 801 -817
73
2016
Kanser riski yüksek kadınlarda profilaktik ooferektomi
Susan M Domcheka , Timothy R Rebbecka
Current Opinion in Obstetrics and Gynecology 19 27 -30
2
2007
Evaluation of veliparib (V) and temozolomide (TMZ) in a phase 2 randomized study of the efficacy and tolerability of V+ TMZ or carboplatin (C) and paclitaxel (P) vs placebo (Plc)+ C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer
V Diéras , HS Han , ME Robson , M Palacova
Cancer Research 77 ( 4 Supp) P42202 -P42202
2
2017
Emotional outcomes in individuals with variant of uncertain significance results from cancer multiplex genetic testing
Jada G Hamilton , Jamie Brower , Dana Clark , Jessica Ebrahimzadeh
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE 28 ( SUPPL 1) S82 -S83
2021
Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations.
Timothy R Rebbeck , Susan M Domchek
LDI issue brief 16 ( 2) 1 -4
11
2010
The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer.
Susan M Domchek
Clinical advances in hematology & oncology 16 ( 5) 330 -332
1
2018
A Population-Based Study of Genes Previously Implicated in Breast Cancer
Katherine L Nathanson , Christine B Ambrosone , Christopher Haiman , Susan Neuhausen
The New England Journal of Medicine 384 ( 5) 440 -451
317
2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Juliette Coignard , Michael Lush , Jonathan Beesley , Tracy A O’mara
Nature Communications 12 ( 1) 1078 -1078
21
2021
Abstract PD9-10: Investigating the clinical utility of tumor mutational burden in predicting rapid progression and death in patients with metastatic breast cancer
Lewis A Chodosh , Susan M Domchek , Angela DeMichele , Michael D Feldman
Cancer Research 81
2021
A prospective controlled study of sexual function and sexually related personal distress up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.
Susan M Domchek , Efrosinia O Krejany , Susan R Davis , Robin J Bell
Menopause
2021
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2.
Katherine Nathanson , Susan M Domchek , Ursina Teitelbaum , Gregory Beatty
Journal of Clinical Oncology
2021
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
Andrew NJ Tutt , Judy E Garber , Bella Kaufman , Giuseppe Viale
The New England Journal of Medicine
520
2021
A counseling framework for moderate-penetrance colorectal cancer susceptibility genes.
Bryson W Katona , Matthew B Yurgelun , Judy E Garber , Kenneth Offit
Genetics in Medicine 20 ( 11) 1324 -1327
14
2018
Pervasive genetic testing
Paul T R Thiruchelvam , Carla S Fisher , Daniel R Leff , Susan M Domchek
The Lancet 391 ( 10135) 2089 -2091
2
2018
Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography
Despina Kontos , Susan M Domchek , Emily F Conant , Katrina Armstrong
BMC Cancer 15 ( 1) 143 -143
14
2015
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma
Timothy Best , Dalin Li , Andrew D Skol , Tomas Kirchhoff
Nature Medicine 17 ( 8) 941 -943
124
2011
Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.
Shandong Wu , Susan P Weinstein , Michael J DeLeo , Emily F Conant
Breast Cancer Research 17 ( 1) 67 -67
37
2015
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
Ana-Teresa Maia , Antonis C Antoniou , Martin O'Reilly , Shamith Samarajiwa
Breast Cancer Research 14 ( 2) 1 -15
19
2012
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
Anna Marie Mulligan , Fergus J Couch , Daniel Barrowdale , Susan M Domchek
Breast Cancer Research 13 ( 6) 1 -20
86
2011
The utility of ductal lavage in breast cancer detection and risk assessment
Susan M Domchek
Breast Cancer Research 4 ( 2) 51 -53
8
2002